A positive immunoreactivity for highly-specific non-mesothelial markers, in particular with claudin-4, tends to exclude MPM, although pulmonary sarcomatoid carcinomas and some sarcomas are negative for claudin-4 [9,102]. Here, CLDN4 is linked to sarcoma.